Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.
You can find text and video tutorials here that explain how to use our system.
Credit rating
Company information
About the company
Muna Therapeutics ApS (CVR number: 41142871) is a company from FREDERIKSBERG. The company recorded a gross profit of -98234 kDKK in 2022. The operating profit was -122.5 mDKK, while net earnings were -127.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was -61.4 %, which can be considered poor and Return on Equity (ROE) was -70.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 81.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Muna Therapeutics ApS's liquidity measured by quick ratio was 4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | |
---|---|---|---|
Volume | |||
Net sales | |||
Gross profit | -8 795.85 | -49 692.75 | -98 234.04 |
EBIT | -10 186.77 | -61 469.09 | - 122 450.03 |
Net earnings | -7 382.11 | -61 518.26 | - 127 682.35 |
Shareholders equity total | 16 657.74 | 162 312.99 | 202 044.95 |
Balance sheet total (assets) | 24 321.12 | 184 063.68 | 247 517.68 |
Net debt | -8 125.35 | - 100 999.50 | - 151 668.83 |
Profitability | |||
EBIT-% | |||
ROA | -41.8 % | -63.3 % | -61.4 % |
ROE | -44.3 % | -68.7 % | -70.1 % |
ROI | -47.0 % | -68.9 % | -68.3 % |
Economic value added (EVA) | -7 350.03 | -56 798.41 | - 116 967.21 |
Solvency | |||
Equity ratio | 68.5 % | 88.2 % | 81.6 % |
Gearing | 30.0 % | 4.6 % | 8.2 % |
Relative net indebtedness % | |||
Liquidity | |||
Quick ratio | 2.1 | 5.3 | 4.0 |
Current ratio | 2.1 | 5.3 | 4.0 |
Cash and cash equivalents | 13 125.34 | 108 532.38 | 168 269.81 |
Capital use efficiency | |||
Trade debtors turnover (days) | |||
Net working capital % | |||
Credit risk | |||
Credit rating | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
... and more!
No registration needed.